drugset / Trial / NCT06945679

Effects of Carica Papaya Leaf Extract (CPLE) in the Outcome of Hospitalized Dengue Patients

NCT06945679

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Its a double-blind placebo controlled multicenter study involving confirmed dengue patients who are hospitalized.168 Patients will be enrolled according to specific inclusion \& exclusion criteria and they will be divided into two equal arms..After taking informed written consent patients will be provided with either CPLE 500 mg 2 capsule 3 times daily for 5 days or placebo and they will be followed up upto discharge from hospital or ICU transfer or death. We want to see the effects of CPLE in the outcome of hospitalized dengue patients in comparison to placebo group. Participants will be asked to take oral CPLE or placebo 500 mg 2 capsules 3 times daily for 5 days.

Timeline

Start
2024-06-01
Primary completion
2025-02-20
Completion
2025-02-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carica Papaya Leaf Extract Unknown 500 mg Oral

Indications